MBOT
MBOT
NASDAQ · Health Care

Microbot Medical Inc

$2.13
+0.00 (+0.00%)
As of May 16, 2:12 AM ET ·
Financial Highlights (FY 2026)
Revenue
1.48B
Net Income
-16,878,073
Gross Margin
82.8%
Profit Margin
-3,241.6%
Rev Growth
-6.1%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 82.8% 82.8% 62.2% 62.2%
Operating Margin -3,302.0% -2,971.8% 25.4% 22.6%
Profit Margin -3,241.6% -3,079.5% 17.2% 19.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.48B 1.58B 39.93M 46.94M
Gross Profit 1.23B 1.31B 24.82M 29.18M
Operating Income -49,031,683,720 -46,995,224,012 10.16M 10.59M
Net Income -16,878,073 -16,177,066 6.88M 9.06M
Gross Margin 82.8% 82.8% 62.2% 62.2%
Operating Margin -3,302.0% -2,971.8% 25.4% 22.6%
Profit Margin -3,241.6% -3,079.5% 17.2% 19.3%
Rev Growth -6.1% -6.1% -1.2% +14.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 23.03M 24.03M
Total Equity 67.54M 68.59M
D/E Ratio 0.34 0.35
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -18,471,787 -18,688,176 11.85M 15.12M
Free Cash Flow 3.52M 6.34M